drugset

drugset / Trial / NCT00004694

Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations

NCT00004694 ↗

Completed 24 enrolled University of Iowa

RandomizedCrossoverSingle-blindTreatment

Summary

OBJECTIVES: I. Determine the safety and efficacy of inhaled and subcutaneously administered heparin in the treatment of hereditary angioedema.

Timeline

Start: 1994-01
Primary completion: —
Completion: 1998-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Heparin	Other / unclassified	—	Subcutaneous

Indications